Estrogen receptor: estrogen
The Transactivating Function 2 (AF 2) of Estrogen Receptor (ER) α Is Indispensable for ERα Mediated Physiological Responses and AF 1 Activity
8
Growth factor activation of the estrogen receptor in vascular cells occurs via a mitogen activated protein kinase independent pathway
12
BRCA1 And Estrogen/Estrogen Receptor In Breast Cancer: Where They Interact?
10
Original Article The expression of transcription factor BORIS and its association with the estrogen receptor beta (ER-β) in cervical carcinogenesis
14
Characterization and prognosis of estrogen receptor positive/progesterone receptor negative male breast cancer: a population based study
8
Estrogen Receptor Antagonists Are Anti Cryptococcal Agents That Directly Bind EF Hand Proteins and Synergize with Fluconazole In Vivo
11
Estrogen receptor transcription and transactivation Estrogen receptor alpha and estrogen receptor beta: regulation by selective estrogen receptor modulators and importance in breast cancer
10
The Role of Estrogen Receptor-a and Estrogen Receptor-b in the Hyperluteinized Mouse Ovary
158
Effects of selective estrogen receptor agonists on estrogen receptor expression in the uterus of ovariectomized rats
9
The therapeutic target of estrogen receptor alpha36 in estrogen dependent tumors
12
Farnesyl transferase inhibitor R115,777 enhances tamoxifen inhibition of MCF 7 cell growth through estrogen receptor dependent and independent pathways
9
Estrogen receptor transcription and transactivation Estrogen receptor knockout mice: what their phenotypes reveal about mechanisms of estrogen action
8
Lead Optimization of Benzoxepin Type Selective Estrogen Receptor (ER) Modulators and Downregulators with Subtype Specific ER alpha and ER beta Activity
85
Estrogen receptor transcription and transactivation Basic aspects of estrogen action
7
Expression of Molecular Biomarkers in Primary Breast Tumors Implanted into a Surrogate Host: Increased Levels of Cyclins Correlate with Tumor Progression
11
Comparative study of ER status in premenopausal and postmenopausal women with carcinoma breast
105
Tamoxifen may prevent both ER+ and ER breast cancers and select for ER carcinogenesis: an alternative hypothesis
6
Oxidative stress and breast cancer biomarkers : the case of the cytochrome P450 2E1
10
A pilot study of the immunogenicity of a 9-peptide breast cancer vaccine plus poly-ICLC in early stage breast cancer
10
Ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy: potential benefits in bone and breast
7